These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29061728)

  • 21. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
    ; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
    Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial.
    de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ;
    Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transurethral Renal Pelvic Denervation: A Feasibility Trial in Patients with Uncontrolled Hypertension.
    Hering D; Nikoleishvili D; Imedadze A; Dughashvili G; Klimiashvili Z; Bekaia E; Shengelia T; Kobalava M; Goguadze O; Emukhvari T; Druker V; Sackner-Bernstein J; Weber MA
    Hypertension; 2022 Dec; 79(12):2787-2795. PubMed ID: 36254733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
    Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
    Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The path of least resistance to success in chronic hypertension?
    Eng MH; Klein AJ
    Catheter Cardiovasc Interv; 2015 Apr; 85(5):887-8. PubMed ID: 25789734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iliac vein stenosis after implantation of a central arteriovenous coupler device in the treatment of therapy resistant arterial hypertension.
    Rosseel L; Scott B; Balmforth P; Sobotka P; Sievert H
    J Hum Hypertens; 2018 Oct; 32(10):691-692. PubMed ID: 30038338
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension: A Randomized Clinical Trial.
    Lopes S; Mesquita-Bastos J; Garcia C; Bertoquini S; Ribau V; Teixeira M; Ribeiro IP; Melo JB; Oliveira J; Figueiredo D; Guimarães GV; Pescatello LS; Polonia J; Alves AJ; Ribeiro F
    JAMA Cardiol; 2021 Nov; 6(11):1317-1323. PubMed ID: 34347008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Davies J; Basile J; Kirtane AJ; Wang Y; Lobo MD; Saxena M; Feyz L; Rader F; Lurz P; Sayer J; Sapoval M; Levy T; Sanghvi K; Abraham J; Sharp ASP; Fisher NDL; Bloch MJ; Reeve-Stoffer H; Coleman L; Mullin C; Mauri L;
    Lancet; 2018 Jun; 391(10137):2335-2345. PubMed ID: 29803590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension. Immediate reduction of blood pressure by iliac arteriovenous anastomosis.
    Edwards JK
    Nat Rev Nephrol; 2015 Mar; 11(3):126. PubMed ID: 25667999
    [No Abstract]   [Full Text] [Related]  

  • 36. Pacemaker-Mediated Programmable Hypertension Control Therapy.
    Neuzil P; Merkely B; Erglis A; Marinskis G; de Groot JR; Schmidinger H; Rodriguez Venegas M; Voskuil M; Sturmberger T; Petru J; Jongejan N; Aichinger J; Kamzola G; Aidietis A; Gellér L; Mraz T; Osztheimer I; Mika Y; Evans S; Burkhoff D; Kuck KH;
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29275370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
    Zhang DY; Cheng YB; Guo QH; Shan XL; Wei FF; Lu F; Sheng CS; Huang QF; Yang CH; Li Y; Wang JG
    Circulation; 2020 Nov; 142(19):1821-1830. PubMed ID: 33019798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial.
    Pedrosa RP; Drager LF; de Paula LKG; Amaro ACS; Bortolotto LA; Lorenzi-Filho G
    Chest; 2013 Nov; 144(5):1487-1494. PubMed ID: 23598607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.